Autism Diagnostics Market Size

Autism Diagnostics Market size is expected to cross USD 5.4 Billion by the end of 2036, growing at a CAGR of 8% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of autism diagnostics was over USD 2 Billion. The growth of the market for autism diagnostics is growing due to advances in biotechnology and increased access to healthcare facilities worldwide. For example, the American Medical Association (AMA) reports that in 2020, U.S. health spending climbed by 9.7% to USD 4.1 trillion, or USD 12,530 per capita.

In addition, manufacturing processes slowed down as a result of some healthcare organizations closing their doors in the early phases of the extraordinary epidemic. Furthermore, the cessation or postponing of therapy sessions for children with autism was caused by the closing of therapy centers and services connected to autism disorders. Nonetheless, telemedicine solutions have been widely adopted by patient caretakers and families due to the rising anxiety levels of autistic patients and their increased vulnerability to COVID-19. This element also raised the market for therapies and other prescription off-label treatments like SSRIs, antipsychotics, and sleep aids. Moreover, a further factor in the market's expansion during COVID-19 was the rise in the use of internet channels to purchase autism drugs.